General Information of the Compound
Compound ID
CP0460845
Compound Name
6-(3-Bromo-5-fluoro-phenyl)-1,4,4-trimethyl-1,4-dihydro-benzo[d][1,3]oxazine-2-thione
    Show/Hide
Structure
Formula
C17H15BrFNOS
Molecular Weight
380.282
Canonical SMILES
CN1C(=S)OC(C)(C)c2cc(ccc12)-c1cc(F)cc(Br)c1
    Show/Hide
InChI
InChI=1S/C17H15BrFNOS/c1-17(2)14-8-10(11-6-12(18)9-13(19)7-11)4-5-15(14)20(3)16(22)21-17/h4-9H,1-3H3
    Show/Hide
InChIKey
AAZLXHMTANMOOL-UHFFFAOYSA-N
Physicochemical Property
logP
5.2416
Rotatable Bonds
1
Heavy Atom Count
22
Polar Areas
12.47
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44275366
ChEMBL ID
CHEMBL28164
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01172, Progesterone receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000078 T-47D Homo sapiens (Human)  2
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
2
IC50 = 100 nM
   TI
   LI
   LO
   TS